GNH USA

Europe — EMA

Nebido (Testosterone Undecanoate)

GNH USA supplies Nebido (Testosterone Undecanoate), a hormone replacement therapy for male hypogonadism and testosterone deficiency. Request a quote today.

Request sourcing

1
Pack/s

What is Testosterone Undecanoate?

Testosterone undecanoate, the active ingredient in Nebido, is an androgen presented as a long‑acting intramuscular injection for intramuscular use. It is used to treat testosterone deficiency in men with hypogonadism, restoring physiological hormone levels. The formulation provides sustained release of testosterone over several weeks, reducing the frequency of injections compared with shorter‑acting preparations.

GNH USA supplies Nebido as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company follows strict quality standards and provides regulatory support for import and distribution in multiple regions.

What is Testosterone Undecanoate used for?

Nebido is an androgen therapy that addresses conditions related to low testosterone production.

Male hypogonadism: restores normal testosterone concentrations and alleviates associated symptoms. Primary hypogonadism: provides long‑acting testosterone replacement to improve sexual function and muscle mass. Secondary hypogonadism: compensates for pituitary or hypothalamic failure, normalizing hormonal balance.

What are the side effects of Testosterone Undecanoate?

Nebido may be associated with a range of adverse reactions, which are classified by frequency and severity.

Common Side Effects: - Injection site pain - Edema - Acne - Increased red blood cell count - Headache - Mood swings

Serious or Rare Side Effects: - Polycythemia - Cardiovascular events (e.g., myocardial infarction) - Liver enzyme elevation - Allergic reactions (anaphylaxis) - Prostate enlargement or cancer progression - Worsening of sleep apnea

What precautions apply to Testosterone Undecanoate?

Before initiating therapy, clinicians should consider several safety measures. - Monitor testosterone levels: adjust dosing based on serum concentrations. - Screen for prostate disease: perform baseline PSA and digital exam. - Assess cardiovascular risk: evaluate history of thromboembolic events. - Avoid in known hypersensitivity: discontinue if allergic reaction occurs. - Use caution in sleep apnea: monitor respiratory status. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

What does Testosterone Undecanoate interact with?

Nebido can interact with other medicines, requiring attention to avoid or monitor effects.

Major Interactions (Avoid): - Warfarin: increased risk of thrombosis and altered INR. - Insulin: may cause unpredictable glucose fluctuations. - Corticosteroids: additive fluid retention and hypertension.

Moderate Interactions (Monitor Closely): - Antihypertensives: testosterone may reduce efficacy, monitor blood pressure. - Statins: possible liver enzyme changes, monitor hepatic function. - Ketoconazole and other strong CYP3A4 inhibitors: may lower testosterone levels.

Frequently asked questions

What is Nebido used for?+
Nebido is prescribed for men with testosterone deficiency, including primary and secondary hypogonadism. By providing a long‑acting source of testosterone, it helps restore normal hormonal balance, improving symptoms such as reduced libido, fatigue, loss of muscle mass, and mood disturbances.
How does testosterone undecanoate work?+
Testosterone undecanoate is a pro‑drug that, after intramuscular injection, is gradually hydrolyzed to active testosterone. The hormone then binds to androgen receptors in target cells, influencing gene expression that drives anabolic activities, supports erythropoiesis, and maintains secondary sexual characteristics.
What is the usual dose of Nebido?+
The dosing regimen for Nebido is determined by the prescribing physician based on the patient’s clinical condition, serum testosterone levels, and response to therapy. Typically, the medication is administered as an intramuscular injection at intervals recommended by the clinician.
Is Nebido safe in pregnancy or breastfeeding?+
Nebido is not indicated for use in pregnant or breastfeeding individuals. Safety data are lacking, and testosterone therapy can affect fetal development and milk production. It should be avoided in these populations unless a clear medical necessity is established by a qualified health professional.
How do I order Nebido from GNH USA?+
To request Nebido, submit an enquiry on the product page at gnh-usa.com with the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain handling), and necessary import documentation.
How does Nebido compare with other testosterone therapies?+
Nebido offers a long‑acting formulation that can be given every 10‑14 weeks, reducing injection frequency compared with short‑acting testosterone esters that require weekly or bi‑weekly dosing. This convenience can improve adherence, though individual response and side‑effect profiles should be evaluated when selecting a therapy.
What are the storage and handling requirements for Nebido?+
Nebido must be stored at 2‑8 °C (refrigerated). Keep the vials in their original packaging, protect them from light, and do not freeze or shake the product. If temporary temperature excursions occur, follow the manufacturer’s guidance before use.
How is Nebido administered?+
Nebido is administered by a qualified health‑care professional as an intramuscular injection, usually into the gluteal muscle. The injection should be performed using aseptic technique, and the dosing interval is set by the prescriber based on therapeutic response.
What are the most serious risks to watch for with Nebido?+
Serious adverse events include polycythemia (elevated red blood cell count), cardiovascular complications such as myocardial infarction or stroke, worsening of sleep‑apnea, and potential progression of prostate disease. Patients should be monitored regularly for hematocrit, cardiovascular status, and prostate health.
Who should not use Nebido?+
Nebido is contraindicated in individuals with known hypersensitivity to testosterone undecanoate, active prostate cancer, severe untreated sleep‑apnea, uncontrolled heart failure, or those who are pregnant or breastfeeding. Caution is also advised for patients with significant liver disease or a history of thromboembolic events.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Testosterone Undecanoate
Route
Intramuscular Use
Manufacturer
Sa Grünenthal N.V.
Origin
EU

Related products